Can nuclear medicine predict response to chemotherapy?
- 1 February 1995
- journal article
- editorial
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 22 (2) , 97-100
- https://doi.org/10.1007/bf00838937
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsPublished by Elsevier ,2003
- Clinical Correlates of MDR1 (P-glycoprotein) Gene Expression in Ovarian and Small-Cell Lung CarcinomasJNCI Journal of the National Cancer Institute, 1992
- Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.Journal of Histochemistry & Cytochemistry, 1990
- THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCEAnnual Review of Biochemistry, 1989
- Uptake and Kinetics of Tc-99m Hexakis 2-Methoxy Isobutyl Isonitrile in Benign and Malignant Lesions in the LungsClinical Nuclear Medicine, 1989
- Multiple-Drug Resistance in Human CancerNew England Journal of Medicine, 1987
- DETECTION OF A MULTIDRUG RESISTANT PHENOTYPE IN ACUTE NON-LYMPHOBLASTIC LEUKAEMIAThe Lancet, 1987
- Amplification and Expression of Genes Associated with Multidrug Resistance in Mammalian CellsScience, 1986
- Human Multidrug-Resistant Cell Lines: Increased mdr 1 Expression Can Precede Gene AmplificationScience, 1986
- Enzymology of Cancer CellsNew England Journal of Medicine, 1977